|
DNAJC9 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.003800E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.683900E-03 |
| Normal-vs-Stage2 |
4.788500E-02 |
| Normal-vs-Stage3 |
2.061400E-01 |
| Normal-vs-Stage4 |
2.977000E-03 |
| Stage1-vs-Stage2 |
7.442400E-01 |
| Stage1-vs-Stage3 |
2.998800E-01 |
| Stage1-vs-Stage4 |
5.132100E-02 |
| Stage2-vs-Stage3 |
3.406600E-01 |
| Stage2-vs-Stage4 |
1.317220E-01 |
| Stage3-vs-Stage4 |
2.181700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.839600E-03 |
| Normal-vs-AfricanAmerican |
4.125900E-02 |
| Normal-vs-Asian |
2.299400E-01 |
| Caucasian-vs-AfricanAmerican |
9.685200E-01 |
| Caucasian-vs-Asian |
3.946000E-01 |
| AfricanAmerican-vs-Asian |
3.469600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.955200E-03 |
| Normal-vs-Female |
1.317970E-02 |
| Male-vs-Female |
6.293200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.920400E-03 |
| Normal-vs-Age(41-60Yrs) |
2.128000E-02 |
| Normal-vs-Age(61-80Yrs) |
7.535100E-03 |
| Normal-vs-Age(81-100Yrs) |
4.810800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.348300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.563900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.284400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.845200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.973600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.556000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.149030E-01 |
| Normal-vs-Grade 2 |
2.897700E-03 |
| Normal-vs-Grade 3 |
1.675620E-01 |
| Normal-vs-Grade 4 |
5.262100E-03 |
| Grade 1-vs-Grade 2 |
7.644200E-01 |
| Grade 1-vs-Grade 3 |
3.997400E-01 |
| Grade 1-vs-Grade 4 |
2.185600E-01 |
| Grade 2-vs-Grade 3 |
6.943500E-02 |
| Grade 2-vs-Grade 4 |
7.897600E-02 |
| Grade 3-vs-Grade 4 |
2.259900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.005240E-01 |
| Normal-vs-ccB subtype |
5.616800E-03 |
| ccA subtype-vs-ccB subtype |
5.238500E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.856490E-02 |
| Normal-vs-N1 |
2.012500E-02 |
| N0-vs-N1 |
5.823600E-02 |
|
|
